Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.38 |
| ▸ | CA2 | P00918 | 8/20 | 0.38 |
| ▸ | CA12 | O43570 | 5/20 | 0.38 |
| ▸ | CA9 | Q16790 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CCNC | P24863 | 1/20 | 0.34 |
| ▸ | CDK8 | P49336 | 1/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15218273 | 0.84 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1MAPTCYP3A4 | |
| SCHEMBL15218276 | 0.80 | TDP1 (0.45) | CA1CA2CA12CA9KMT2A | |
| SCHEMBL13201475 | 0.75 | ALDH1A1 (0.55) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL15218272 | 0.74 | TDP1 (0.35) | KMT2AMEN1TDP1 | |
| SCHEMBL1926110 | 0.73 | CA1 (0.52) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL30069900 | 0.72 | ALDH1A1 (0.45) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL28578349 | 0.71 | CA1 (0.53) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL5241017 | 0.69 | CA1 (0.57) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL6509909 | 0.68 | CA1 (0.43) | CA1CA2CA12CA9ALDH1A1 | |
| SCHEMBL25848715 | 0.67 | ALDH1A1 (0.54) | CA1CA2CA12CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130225789-A1 | Polyethylene Glycol Having Hetero Multiple Functional Groups | SUN YI (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225789-A1 | Polyethylene Glycol Having Hetero Multiple Functional Groups | CLTB, GMFG, HDGF | CA1 3367/4885CA2 4687/4885CA12 1422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.